Avbunudiagba John Afokoghene, Alalor Christian Arerusuoghene, Okolocha Queen Dorcas
Delta State University, Pharmaceutics and Industrial Pharmacy Department, Abraka, Nigeria.
Turk J Pharm Sci. 2020 Dec 23;17(6):645-652. doi: 10.4274/tjps.galenos.2019.53325.
Bilayer floating drug delivery is an approach that helps to overcome the shortcomings of single-layered tablets. There is little or no fluctuation of the drug in the blood stream or tissue, while control is enabled over the time and site of drug release. In the current study, bilayer theophylline matrix tablets were formulated by double compression and evaluated using granules produced by polymeric granulation and simple coacervation techniques.
Bilayer floating theophylline tablets containing an immediate release layer (IRL) and a sustained release layer (SRL) were prepared. Granules for the IRL section were produced by wet granulation, while those for the SRL section were produced by polymeric granulation and simple coacervation techniques using Eudragit RL100 and carboxymethyl cellulose (CMC) as binder. The resulting granules were characterized for flowability and packing properties. Granules with adequate flow were compressed into flat-faced tablets 12 mm in diameter using a single punch tableting machine at an arbitrary load of 28 kgF on a load scale. The tablets were evaluated for hardness, weight variability, disintegration, friability, swelling index, floating time, and drug release.
The angle of repose and Hausner ratio were 29.07±0.330 to 40.08±0.660 and 1.07±0.01 to 1.28±0.01, respectively. Tablets hardness values ranged from 4.74±0.36 to 9.84±0.49 kgF, while percentage friability ranged from 0.5% to 1.51%. Floating lag time was between 1±0.41 and 9±0.71 min, while the total floating time was between 1 min and 9 h. Over 50% of the drug was released within 7 h.
Drug release from the tablets showed a prompt release phase and an extended release phase. Therefore, appropriate combination of Eudragit and CMC and the right reagent can produce well retarded bilayer floating tablets.
双层漂浮给药是一种有助于克服单层片剂缺点的方法。药物在血流或组织中的波动很小或没有波动,同时能够控制药物释放的时间和部位。在本研究中,通过二次压片制备了双层茶碱基质片剂,并使用聚合物制粒和简单凝聚技术制备的颗粒进行了评价。
制备了含有速释层(IRL)和缓释层(SRL)的双层漂浮茶碱片。IRL部分的颗粒通过湿法制粒制备,而SRL部分的颗粒通过聚合物制粒和简单凝聚技术制备,使用Eudragit RL100和羧甲基纤维素(CMC)作为粘合剂。对所得颗粒的流动性和堆积性能进行了表征。使用单冲压片机在负载秤上以28 kgF的任意负载将具有适当流动性的颗粒压制成直径为12 mm的平面片剂。对片剂的硬度、重量差异、崩解、脆碎度、溶胀指数、漂浮时间和药物释放进行了评价。
休止角和豪斯纳比分别为29.07±0.330至40.08±0.660和1.07±0.01至1.28±0.01。片剂硬度值范围为4.74±0.36至9.84±0.49 kgF,脆碎度百分比范围为0.5%至1.51%。漂浮滞后时间在1±0.41至9±0.71分钟之间,而总漂浮时间在1分钟至9小时之间。超过50%的药物在7小时内释放。
片剂的药物释放呈现速释阶段和缓释阶段。因此,Eudragit和CMC的适当组合以及合适的试剂可以制备出缓释良好的双层漂浮片剂。